Search Count: 27
All
Selected
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2026-03-11 Classification: OXIDOREDUCTASE Ligands: ACT, VVO, VY9 |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2026-03-11 Classification: OXIDOREDUCTASE Ligands: ACT, VVO, 7UC |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2026-03-11 Classification: OXIDOREDUCTASE Ligands: VY9, VVO, ACT |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2026-03-11 Classification: OXIDOREDUCTASE Ligands: ACT, VY9, VVO |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2026-03-11 Classification: OXIDOREDUCTASE Ligands: ACT, VVO |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.36 Å Release Date: 2026-03-11 Classification: OXIDOREDUCTASE Ligands: ACT, VY9, VVO, PEG |
![]() |
Organism: Actinoplanes teichomyceticus
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2025-11-19 Classification: BIOSYNTHETIC PROTEIN Ligands: LYS, SIN, PGE, VVO, CL, FLC, V |
![]() |
Organism: Streptomyces roseifaciens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2025-11-19 Classification: BIOSYNTHETIC PROTEIN Ligands: VVO, SIN |
![]() |
Organism: Actinoplanes teichomyceticus
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2025-11-19 Classification: BIOSYNTHETIC PROTEIN Ligands: LYS, SIN, VVO, CL |
![]() |
Organism: Actinoplanes teichomyceticus
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2025-11-19 Classification: BIOSYNTHETIC PROTEIN Ligands: LYS, SIN, VVO, CL, V |
![]() |
Organism: Actinoplanes teichomyceticus
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2025-11-19 Classification: BIOSYNTHETIC PROTEIN Ligands: LYS, SIN, VVO, CL, V |
![]() |
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2025-09-24 Classification: HYDROLASE Ligands: DVT, URI, VVO |
![]() |
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2025-09-24 Classification: HYDROLASE Ligands: DVT, FJF, VVO |
![]() |
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2025-09-24 Classification: HYDROLASE Ligands: 8IZ, DVT, VVO |
![]() |
X-Ray Structure Of Decavanadate/Lysozyme Adduct Obtained When The Protein Is Treated With Cs2[V(V)2O4(Mal)2]2H2O (Structure A)
Organism: Gallus gallus
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2025-08-13 Classification: HYDROLASE Ligands: CL, NA, DVT, A1JFD, VVO |
![]() |
X-Ray Structure Of Lysozyme When Is Treated With Cs2[V(V)2O4(Mal)2]2H2O At 310K
Organism: Gallus gallus
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2025-08-13 Classification: HYDROLASE Ligands: CL, NA, VVO |
![]() |
X-Ray Structure Of Lysozyme Obtained Upon Reaction With [Vivo(8-Hq)2] In Sodium Formate
Organism: Gallus gallus
Method: X-RAY DIFFRACTION Resolution:1.21 Å Release Date: 2025-02-12 Classification: HYDROLASE Ligands: EPE, A1H23, VVO, VVB |
![]() |
Crystal Structure Of Hrmj From Streptomyces Sp. Cfmr 7 (Hrmj-Ssc) Complexed With Vanadyl(Iv)-Oxo, Succinate And 6-Nitronorleucine
Organism: Streptomyces sp. cfmr 7
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2025-02-12 Classification: OXIDOREDUCTASE Ligands: 6HN, VVO, SIN, GOL, BR |
![]() |
Crystal Structure Of Hrmj From Streptomyces Sp. Ag109_G2-6 (Hrmj-Ssa) Complexed With Vanadyl(Iv)-Oxo And Succinate
Organism: Streptomyces sp. ag109_g2-6
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-02-12 Classification: OXIDOREDUCTASE Ligands: SIN, VVO |
![]() |
Room Temperature Xfel Isopenicillin N Synthase Structure In Complex With The Fe(Iv)=O Mimic Vo And Acv.
Organism: Emericella nidulans (strain fgsc a4 / atcc 38163 / cbs 112.46 / nrrl 194 / m139)
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2022-01-12 Classification: OXIDOREDUCTASE Ligands: SO4, ACV, VVO |




















